Stryker Corporation

NYSE:SYK

Medical - Devices

Healthcare
$318.15 +3.08%

+$9.29 today

Market cap
$121.12B
Beta
0.79
P/E (TTM)
35.6
EPS (TTM)
$8.72
Dividend yield
1.11%
52W Low $281.00High $404.87

Volume 3.25M

Average 2.49M

SYK Inventory

Raw materials, work in progress, and finished goods held for sale.

Stryker CorporationNYSE: SYK

Inventory · Q2 FY2026 · quarter ended Jun 2026

Inventory rises 4.4% from a year ago

Inventory stood at $5.52B at the end of Q2 FY2026, up 4.4% from a year earlier and up 1.9% from the prior quarter. Over 3 fiscal years it compounded at +9.9% a year.

Context

  • Inventory amounted to 11.5% of total assets at the end of Q2 FY2026, up 0.1 pp from a year earlier.
  • Inventory increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether inventory keeps rising in the next quarterly balance sheet after a +4.4% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$5.52B+1.9% QoQ
Last fiscal yearDec 2025
$5.31B+11.2% YoY
Year agoJun 2025
$5.29B+4.4% since
Inventory past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+4.4%——
1 year+11.2%——
3-year CAGR+9.9%——
5-year CAGR——
10-year CAGR——

Inventory history

USD · from the balance sheet

Latest · FY2025
5.31B USD
Year-over-year change
+11.2%
4-year CAGR
+12.5%

Inventory vs competitors

How SYK compares with its peers on the latest reported figures

  • SYK's Jun 2026 inventory of $5.52B is the highest of the 11 companies compared; the peer median is $276.07M.
  • Its year-over-year change of +4.4% is the 5th highest of 11, against a peer median of +3.0%.
  • Inventory amounts to 11.5% of total assets for SYK, versus a peer median of 15.8%.
SYK Competitors Peer median
Inventory for SYK and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
SYKStryker CorporationJun 2026$5.52B +4.4%+9.9%11.5%
SNNSmith & Nephew plcDec 2025$2.12B -11.3%-1.3%20.2%
GMEDGlobus Medical, Inc.Jun 2026$810.9M +5.0%+36.4%14.8%
ENOVEnovis CorporationApr 2026$602.54M +2.8%+11.1%15.7%
IARTIntegra LifeSciences Holdings CorporationMar 2026$495.04M +11.1%+14.9%13.8%
CNMDCONMED CorporationMar 2026$366.11M +3.2%+2.3%15.8%
ATECAlphatec Holdings, Inc.Mar 2026$186.03M +8.9%+18.6%23.3%
OFIXOrthofix Medical Inc.Mar 2026$177.82M +1.9%-30.1%20.1%
XTNTXtant Medical Holdings, Inc.Mar 2026$31.88M -17.9%+20.5%40.9%
ZBHZimmer Biomet Holdings, Inc.Jun 2026$0 -100.0%+2.1%0.0%
MDTMedtronic plcJul 2026-$240M +35.7%+4.0%0.3%
Peer median (excluding SYK) $276.07M+3.0%+7.5%15.8%

Competitors are the stored peer set for SYK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents2.94B1.84B2.97B3.65B4.01B
Short-term Investments75M84M82M841M89M
Net Receivables3.02B3.57B3.77B3.99B4.04B
Inventory3.31B4B4.84B4.77B5.31B
Other Current Assets662M787M857M1.59B1.31B
Total Current Assets10.02B10.28B12.52B14.85B14.76B
Property, Plant & Equipment (Net)3.25B3.44B3.71B3.96B4.4B
Goodwill12.92B14.88B15.24B15.86B19.29B
Intangible Assets4.84B4.89B4.59B4.4B5.68B
Long-term Investments66M90M2M39M2M
Tax Assets1.76B1.41B1.67B1.74B1.1B
Other Non-current Assets1.78B1.9B2.18B2.13B2.62B
Total Non-current Assets24.61B26.61B27.39B28.12B33.09B
Total Assets34.63B36.88B39.91B42.97B47.84B
Account Payables1.13B1.41B1.52B1.68B1.8B
Short-term Debt119M1.31B2.24B1.55B1.15B
Tax Payables192M292M391M539M0
Deferred Revenue00000
Other Current Liabilities2.02B2.14B2.3B2.44B2.49B
Total Current Liabilities4.55B6.3B7.92B7.62B7.79B
Long-term Debt12.47B11.86B10.9B12.19B14.86B
Deferred Tax Liabilities68M67M63M82M137M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities2.36B1.68B2.08B2.07B2.29B
Total Non-current Liabilities15.21B13.97B13.4B14.72B17.63B
Total Liabilities19.75B20.27B21.32B22.34B25.42B
Common Stock38M38M38M38M38M
Retained Earnings13.48B14.77B16.77B18.53B20.47B
Accumulated OCI(531M)(221M)(416M)(293M)(687M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity14.88B16.62B18.59B20.63B22.42B
Total Debt12.9B13.53B13.49B14.12B16.36B
Net Debt9.96B11.68B10.52B10.47B12.35B

Stryker Corporation

NYSE:SYK

Intrinsic Alpha fair value

Locked

Current Price

$318.15

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.